[局部提巴尼布林在治疗行动性角质炎中的有效性.]
1Dermatologia Clinica, Dipartimento di Medicina Clinica e Chirurgia, Università Federico II, Napoli.
Recenti progressi in medicina
|October 24, 2024
概括
局部提尔巴尼布林 1% 药膏在76岁的男性中有效治疗了动作性角质瘤 (AKs),包括II级病变. 这一案例突出了提尔巴尼布林的存在.
科学领域:
- 皮肤病学 皮肤病学
- 在瘤学瘤学.
背景情况:
- 行为性角质瘤 (AKs) 是一种常见的癌前皮肤病变.
- 癌化场 (FC) 表示有亚临床AK的阳光照射区域.
- 治疗选择通常取决于AK的严重程度 (奥尔森等级).
研究的目的:
- 报告局部提巴尼布林1%膏在治疗行动性角质瘤,包括II级病变的疗效和安全性.
- 评估提尔巴尼布林在患有广泛野外癌症和先前治疗失败的患者中的有效性.
主要方法:
- 一个76岁的男性患者的案例研究,患有多种面部和头皮AKs.
- 局部提尔巴尼布林 1% 药膏被应用于一个大范围的癌症领域,涉及一级和二级 AKs.
- 在治疗后10天和8周评估了患者的结果.
主要成果:
- 患者经历了10天后的红血和皮,并有可控的灼热感.
- 在8周的随访期间,观察到行动性角质完全消失.
- 没有发现任何残留的局部副作用,表明安全性和耐受性良好.
结论:
- 局部用tirbanibulin 1%膏在癌症领域内治疗I级和II级动态角质瘤时显示出有效性和安全性.
- 这一案例表明,除了目前批准用于I级AKS的提尔巴尼布林外,它还可能具有更广泛的适用性.
- 提尔巴尼布林提供了一种安全有效的治疗选择,结合了疗效,安全性和患者遵守性.
相关概念视频
Skin Cancer
3.9K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.9K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)

